Immunotherapeutic progress and application of bispecific antibody in cancer

Overview of attention for article published in Frontiers in immunology, October 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 30 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 52,520 followers.

Immunotherapeutic progress and application of bispecific antibody in cancer: Bispecific antibodies (bsAbs) are artificial antibodies with two distinct antigen-binding sites that can bind to different antigens or different… #immunology https://t.co/4WZoJY2S

23 Oct 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Immunotherapeutic progress and application of bispecific antibody in cancer: Bispecific antibodies (bsAbs)…

21 Oct 2022

Reply Repost Favourite

@alanlparker

21 Oct 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Immunotherapeutic progress and application of bispecific antibody in cancer: Bispecific antibodies (bsAbs)…

21 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.